Brown PD - Search Results

1

Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).

Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Eccles SA, et al. Among authors: brown pd. Cancer Res. 1996 Jun 15;56(12):2815-22. Cancer Res. 1996. PMID: 8665519

2

Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.

Giavazzi R, Garofalo A, Ferri C, Lucchini V, Bone EA, Chiari S, Brown PD, Nicoletti MI, Taraboletti G. Giavazzi R, et al. Among authors: brown pd. Clin Cancer Res. 1998 Apr;4(4):985-92. Clin Cancer Res. 1998. PMID: 9563894

3

Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.

Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Watson SA, et al. Among authors: brown pd. Cancer Res. 1995 Aug 15;55(16):3629-33. Cancer Res. 1995. PMID: 7627972

4

Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.

Macaulay VM, O'Byrne KJ, Saunders MP, Braybrooke JP, Long L, Gleeson F, Mason CS, Harris AL, Brown P, Talbot DC. Macaulay VM, et al. Clin Cancer Res. 1999 Mar;5(3):513-20. Clin Cancer Res. 1999. PMID: 10100701 Clinical Trial.

5

Preclinical and clinical studies of MMP inhibitors in cancer.

Drummond AH, Beckett P, Brown PD, Bone EA, Davidson AH, Galloway WA, Gearing AJ, Huxley P, Laber D, McCourt M, Whittaker M, Wood LM, Wright A. Drummond AH, et al. Among authors: brown pd. Ann N Y Acad Sci. 1999 Jun 30;878:228-35. doi: 10.1111/j.1749-6632.1999.tb07688.x. Ann N Y Acad Sci. 1999. PMID: 10415734 Review.

6

Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.

Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Wang X, et al. Among authors: brown pd. Cancer Res. 1994 Sep 1;54(17):4726-8. Cancer Res. 1994. PMID: 8062271

7

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.

Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. Davies B, et al. Among authors: brown pd. Cancer Res. 1993 May 1;53(9):2087-91. Cancer Res. 1993. PMID: 8347186

8

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.

Watson SA, Morris TM, Parsons SL, Steele RJ, Brown PD. Watson SA, et al. Among authors: brown pd. Br J Cancer. 1996 Nov;74(9):1354-8. doi: 10.1038/bjc.1996.549. Br J Cancer. 1996. PMID: 8912529 Free PMC article.

9

Matrix metalloproteinase inhibitors.

Brown PD. Brown PD. Breast Cancer Res Treat. 1998;52(1-3):125-36. doi: 10.1023/a:1006119319695. Breast Cancer Res Treat. 1998. PMID: 10066077 Review.

10

Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.

Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R. Chirivi RG, et al. Among authors: brown pd. Int J Cancer. 1994 Aug 1;58(3):460-4. doi: 10.1002/ijc.2910580326. Int J Cancer. 1994. PMID: 8050828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters